Showing results (511-520 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|January 7, 2020
Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndromeXiaolan Mo, Jiali Li, Yunfeng Liu, et al.
The Pharmacogenomics Journal|May 17, 2006
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatmentJ Kirchheiner, K Nickchen, J Sasse, et al.
The Pharmacogenomics Journal|May 17, 2006
Pharmacogenetic of antirheumatic treatments: clinical implicationsG Ferraccioli, B Tolusso, M De Santis
The Pharmacogenomics Journal|May 17, 2006
The serotonin transporter gene polymorphism is not associated with smoking behaviorO Trummer, H Köppel, T C Wascher, et al.
The Pharmacogenomics Journal|August 17, 2005
Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of actionR Huang, A Wallqvist, N Thanki, et al.
The Pharmacogenomics Journal|March 23, 2005
Sequencing drug response with HapMapM Lin, C Aquilante, J A Johnson, et al.
The Pharmacogenomics Journal|September 15, 2005
Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genesM Fiegenbaum, F R Silveira, C R Van der Sand, et al.
The Pharmacogenomics Journal|July 20, 2005
Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?J Fernø, M B Raeder, A O Vik-Mo, et al.
The Pharmacogenomics Journal|July 26, 2005
Only low levels of exogenous N-acetyltransferase can be achieved in transgenic miceW Cao, B Chau, R Hunter, et al.
The Pharmacogenomics Journal|July 27, 2005
Pharmacologic profiling of transcriptional targets deciphers promoter logicW J Freebern, C M Haggerty, I Montano, et al.
Pageof 135